Zhibao Technology's Subsidiary, Zhibao Health, Launches the "Ren Ren Kang Yue" Product in Collaboration with the People's Insurance Company of China
Zhibao Technology (NASDAQ: ZBAO) has launched "Ren Ren Kang Yue," a new middle-market medical insurance product, in partnership with People's Insurance Company of China (PICC). The product, launched on August 26, 2025, targets urban residents aged 20-50 years old in China.
The insurance offering provides access to VIP and International wards of public hospitals and selected private providers, with plans starting at RMB 840 (USD $117) per year. The product will be distributed through PICC's nationwide network, Zhibao's subsidiary Sunshine Insurance Brokers, and third-party channels.
This launch represents the first product in a series of strategic collaborations between Zhibao and PICC, following their partnership announcement in December 2024, aimed at serving China's growing middle class with affordable healthcare coverage.
- Strategic partnership with PICC, one of China's largest P&C insurance companies
- Multi-channel distribution through PICC's nationwide network and Zhibao's subsidiary
- Affordable pricing starting at RMB 840/year targeting the growing middle class
- Product offers premium medical services access through VIP/International wards
- None.
Insights
Zhibao's new mid-market medical insurance product with PICC strengthens their market position and diversifies revenue streams in China's growing InsurTech sector.
Zhibao Technology's strategic partnership with PICC to launch the "Ren Ren Kang Yue" medical insurance product represents a calculated move to capture the underserved middle-market segment in China's insurance landscape. Targeting urban residents aged 20-50, this product cleverly positions itself with mid-tier pricing (starting at
The product's value proposition lies in its access to VIP and International wards in public hospitals along with selected private providers—a significant differentiator in China's healthcare system. These wards function as premium service centers within established public hospitals, offering enhanced care while maintaining access to the institution's broader medical resources.
The multi-channel distribution strategy through PICC's nationwide network, Zhibao's Sunshine Insurance Brokers subsidiary, and third-party platforms creates substantial market reach. Additionally, the product's connection to PICC's existing "Ren Ren An Kang" line provides a natural upgrade path for current customers during renewal cycles, potentially improving conversion rates.
This launch represents the first in what's described as a series of strategic cooperation products with PICC, suggesting a long-term partnership trajectory rather than a one-off collaboration. The relationship with PICC—one of China's largest P&C insurers—provides Zhibao with enhanced credibility and distribution capabilities while allowing them to focus on their technological and market expertise contributions.
From a business perspective, this product diversifies Zhibao's revenue streams while leveraging their existing technological infrastructure and medical network. The focus on China's growing middle class targets a demographic with increasing disposable income and rising healthcare consciousness, positioning the company to potentially capture significant market share in this expanding segment.
Shanghai, China--(Newsfile Corp. - September 17, 2025) - Zhibao Technology Inc. (NASDAQ: ZBAO) ("Zhibao," "we," or the "Company"), a leading and high growth InsurTech company primarily engaging in providing digital insurance brokerage services through its operating entities in China, today announced its wholly owned subsidiary Zhibao Health, has officially launched the "Ren Ren Kang Yue" product in collaboration with the People's Insurance Company of China ("PICC") on August 26, 2025.
This new product is a middle-market medical insurance product designed to cover the needs of urban residents, between the ages of 20-50 years old, within China. With a slogan of "mid-end prices, high-end quality," this product includes convenient services including direct billing, access to the VIP or International wards of public hospitals in China, and access to selected private providers, while remaining affordable to meet the needs of young professionals and families. Within the Chinese medical system, VIP and International wards provide access to premium medical services within the setting of the wider hospital, allowing patients access to high-end services while still retaining access to the doctors and resources of leading public hospitals.
This offering will be sold through three separate channels, including PICC's nationwide sales network, as well as through Zhibao's subsidiary, Sunshine Insurance Brokers, in addition to third-party channels and platforms.
The "Ren Ren Kang Yue" product extends PICC's own "Ren Ren An Kang" product line, a social medical insurance supplemental policy, and provides existing customers with an additional upgrade option during their renewal cycle. This product represents the first in a series of strategic cooperation products with PICC as both companies are committed to providing affordable, high-quality medical insurance products across China.
"I am pleased to announce a new insurance product line with our PICC partner that delivers healthcare services to a wider, more diverse population, and promotes the Company's mission of providing affordable healthcare coverage through various technology channels to China's middle class. We believe our strategic partnership with PICC underscores Zhibao's long-standing commitment to providing innovative insurance solutions and driving growth within the Chinese insurance market. We look forward to strengthening and deepening our relationship with one of China's largest P&C insurance companies across medical and other product lines in the future," said Mr. Botao Ma, Chief Executive Officer of Zhibao Technology.
The "Ren Ren Kang Yue" product went live on Monday, August 18, 2025, with the first policies being issued the same day. We believe this product is designed to provide high quality, yet affordable coverage with plans starting at RMB 840/USD
In December 2024, the Company announced a strategic partnership with PICC to launch a new generation of medical insurance products in China. This collaboration was expected to leverage the strengths of both partners to deliver a comprehensive and innovative medical insurance solution tailored to meet the needs of China's growing middle class.
We believe Zhibao's deep knowledge of the Chinese insurance market and its technological expertise are central to the development of this product, as well as to customer service and claims processing. We believe the Company's extensive medical network further ensures efficient, high-quality healthcare services for policyholders nationwide.
About Zhibao Technology Inc.
Zhibao Technology Inc. (NASDAQ: ZBAO) is a leading and high growth InsurTech company primarily engaging in providing digital insurance brokerage services through its operating entities ("Zhibao China Group") in China. 2B2C ("to-business-to-customer") digital embedded insurance is the Company's innovative business model, which Zhibao China Group pioneered in China. Zhibao China Group launched the first digital insurance brokerage platform in China in 2020, which is powered by their proprietary PaaS ("Platform as a Service").
Zhibao has developed over 40 proprietary and innovative digital insurance solutions addressing different scenarios in a wide range of industries, including but not limited to travel, sports, logistics, utilities, and e-commerce. Zhibao acquires and analyzes customer data, utilize big data and AI technology to continually iterate and enhance its digital insurance solutions. This iterative process, in addition to continually improving its digital insurance solutions, will keep it abreast of the new trends and customer preferences in the market. For more information, please visit: ir.zhibao-tech.com.
Forward-Looking Statements
Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "is/are likely to," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations that arise after the date hereof, except as may be required by law. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the "Risk Factors" section of our annual reports on Form 20-F (as amended) and registration statements on Form F-1 (as amended) and Form F-3 (as amended) that have been filed or will be filed from time to time with the SEC. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statements and other filings with the SEC. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov.
Investor Relations Contact
Zhibao Technology Inc.
Investor Relations
Office Email: ir@zhibao-tech.com
Skyline Corporate Communications Group, LLC
Scott Powell, President
Avenues Tower 1177 Avenue of the Americas, 5th floor
New York, NY 10036
Office: (646) 893-5835
Email: info@skylineccg.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/266806
FAQ
What is Zhibao Technology's (NASDAQ: ZBAO) new insurance product 'Ren Ren Kang Yue'?
When did Zhibao Technology launch the Ren Ren Kang Yue insurance product?
How much does Zhibao's Ren Ren Kang Yue insurance cost?
How will Zhibao Technology distribute the Ren Ren Kang Yue insurance product?
What benefits does Zhibao's Ren Ren Kang Yue insurance provide?
